The Small Molecule Screening and Synthesis Facility (SMSSF) fosters collaborative drug discovery research between chemists, biologists and physician scientists that leads to the identification of new small molecules that inhibit cancer phenotypes in cellular or animal models and that can be further developed for clinical evaluation in human cancer patients.
Our drug discovery services include:
News and Accomplishments
Tip-less, acoustic liquid dispensing of aqueous and DMSO solutions in 2.5nanoliter(!) and up volumes into 96, 384 and 1536-well plates is now available for any application on an Echo 555.
View the Small Molecule Screening and Synthesis Facility's Scientific Accomplishments.
Funding received from the UWCCC Cancer Center Support Grant (CCSG) for published research, including the use of UWCCC Shared Resources to generate or analyze data, or conduct clinical trials, needs to reference the UWCCC. See Acknowledging UWCCC in Publications, Posters and Presentations.
View the UW Drug Discovery and Development website for more information on other UW-Madison laboratory facilities that provide state-of-the-art instrumentation and expert scientific staff.